Beijing-based artificial intelligence company Z.AI is raising about $5 billion in Hong Kong, according to term sheets seen by Reuters. The company plans to place roughly $2 billion in new shares and sell about $3 billion in zero-coupon convertible bonds, with the proceeds earmarked for research and development and additional computing infrastructure.
The move comes as AI companies worldwide race to secure capital for the massive computing power needed to train and run large language models. For everyday investors, this deal is a window into how fast-growing tech firms are funding their ambitions—and the trade-offs they are willing to make.
How the deal is structured
Z.AI is placing 21.97 million new Hong Kong shares at HK$714 each. That price is about 10% below Friday's close of HK$793, a typical discount designed to attract large institutional buyers quickly. Share placements like this are common in Hong Kong and other Asian markets when companies want to raise equity capital without a lengthy public offering process.
In a separate but parallel move, Z.AI is issuing 20.14 billion yuan (roughly $2.8 billion) of zero-coupon convertible bonds due in September 2027. These bonds pay no regular interest and are priced around face value, implying a yield between negative 0.5% and zero. In plain terms, investors are lending money to Z.AI at essentially no cost—or even paying a small premium—because they also receive the right to convert the bonds into shares at a future date.
The conversion price is initially set at HK$892.50 per share, a 25% premium to the placement price. That means the stock must rise meaningfully above the placement level before conversion becomes attractive. Z.AI also has the option to call, or redeem, the bonds from February 18, 2027, if the shares trade at or above 130% of the conversion price—a standard feature that lets the company force conversion if its stock performs well.
By keeping the two deals independent, Z.AI ensures that one can close even if the other falls through. This reduces execution risk and gives the company flexibility in a volatile market.
Why zero-coupon convertibles?
Zero-coupon convertible bonds are a hybrid instrument: they combine a bond's safety with a stock option's upside. Investors receive no interest payments, but they get the right to convert into equity at a set price. For the issuing company, the appeal is clear—it can raise money without paying cash interest, which is especially valuable for firms that are burning through cash to fund growth.
For investors, the trade-off is that they are taking on equity risk without any guaranteed return. If the stock falls, the bond's value will likely fall too, and there is no interest income to cushion the blow. That is why these instruments are typically bought by sophisticated institutional investors who understand the risks.
Z.AI's decision to use this structure reflects a broader trend among AI companies, which often have high capital needs but uncertain near-term profitability. By mixing straight equity with equity-linked debt, Z.AI is balancing dilution for existing shareholders against the cost of capital.
What it means for investors
For ordinary investors, the key takeaway is that Z.AI is betting heavily on its ability to grow into its valuation. The share placement at a discount signals that the company wants to raise money quickly, while the convertible bond's conversion premium suggests management expects the stock to rise over the next couple of years.
However, there are risks. The discount on the placement could pressure the stock in the short term, as new shares enter the market at a lower price. And if Z.AI's growth slows or AI competition intensifies, the convertible bonds could become a drag on the company's balance sheet.
Investors should also note that this is a company-specific story, not a signal about the broader AI sector. While other tech firms are also raising large sums to build out infrastructure, each deal has its own terms and risks.
For those watching the AI space, the next thing to look for is how Z.AI deploys the capital and whether it can show progress in its R&D pipeline. The company's ability to convert these funds into competitive products will ultimately determine whether the financing was a smart move or a costly one.
As always, this is not a recommendation to buy or sell Z.AI shares. It's simply a look at how one of the world's most capital-hungry industries is funding its future—and what that means for the investors who back it.
